These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 203869)

  • 21. The effect of in vivo deprenyl on cerebral amine system in rats with portocaval shunts.
    Fogel WA; Andrzejewski W; Sasiak K; Maslinski C
    Inflamm Res; 2000 Apr; 49 Suppl 1():S45-6. PubMed ID: 10864416
    [No Abstract]   [Full Text] [Related]  

  • 22. Antagonism of a behavioral effect of LSD and lisuride in the cat.
    White FJ; Holohean AM; Appel JB
    Psychopharmacology (Berl); 1983; 80(1):83-4. PubMed ID: 6408677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some kinetic and inhibition properties of human brain mitochondrial monoamine oxidase (EC 1.4.3.4).
    Jain M; Bakutis E; Gayle T; Lansky P
    Neurobiology; 1974; 4(3):180-90. PubMed ID: 4367441
    [No Abstract]   [Full Text] [Related]  

  • 24. Brain monoamine oxidase activity after in vivo-chronic iprindole treatment.
    Ortega-Corona BG; Carranza J; Sosa A; Guzmán-Amaya P; Esparza-Avalos NS; Castro-Osuna G
    Pharmacol Biochem Behav; 1981 Dec; 15(6):951-4. PubMed ID: 6172802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.
    Carlsson A; Adolfsson R; Aquilonius SM; Gottfries CG; Oreland L; Svennerholm L; Winblad B
    Adv Biochem Psychopharmacol; 1980; 23():295-304. PubMed ID: 6156586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
    Jacoby JH; Poulakos JJ
    J Pharm Pharmacol; 1977 Dec; 29(12):771-3. PubMed ID: 22629
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of quipazine and LSD on monoamines in the rat striatum.
    Miśkiewicz M; Rokosz-Pelc A; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(5):489-92. PubMed ID: 94944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-lysergic acid diethylamide (LSD)--effect on biogenic amines excretion in man.
    Messiha FS; Grof S
    Biochem Pharmacol; 1973 Sep; 22(18):2352-4. PubMed ID: 4733686
    [No Abstract]   [Full Text] [Related]  

  • 29. Block by LSD of the increase in brain serotonin turnover induced by elevated ambient temperature.
    Aghajanian GK; Weiss BL
    Nature; 1968 Nov; 220(5169):795-6. PubMed ID: 5698754
    [No Abstract]   [Full Text] [Related]  

  • 30. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings: Effect of LSD on rat brain 5-hydroxy-tryptamine metabolism at elevated environmental temperature.
    Curzon G; Marsden CA
    Br J Pharmacol; 1976 Mar; 56(3):368P-369P. PubMed ID: 1260198
    [No Abstract]   [Full Text] [Related]  

  • 33. Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors.
    Prada MD; Saner A; Burkark WP; Bartholini G; Pletscher A
    Brain Res; 1975 Aug; 94(1):67-73. PubMed ID: 1148867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin involvement in lisuride-induced mounting and in sleep.
    Da Prada M; Bonetti EP; Scherschlicht R; Bondiolotti GP
    Pharmacopsychiatry; 1985 Mar; 18(2):202-8. PubMed ID: 2991955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist.
    Burris KD; Breeding M; Sanders-Bush E
    J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine.
    Rosecrans JA; Lovell RA; Freedman DX
    Biochem Pharmacol; 1967 Oct; 16(10):2011-21. PubMed ID: 6065966
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biogenic amines in the pathogenesis of different forms of viral infections].
    Popenenkova ZA; Maslennikov GA
    Vestn Akad Med Nauk SSSR; 1977; (7):83-92. PubMed ID: 197741
    [No Abstract]   [Full Text] [Related]  

  • 38. Biogenic amines and affective disorders.
    Schildkraut JJ
    Annu Rev Med; 1974; 25(0):333-48. PubMed ID: 4368455
    [No Abstract]   [Full Text] [Related]  

  • 39. Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide.
    Adams LM; Geyer MA
    Pharmacol Biochem Behav; 1985 Sep; 23(3):461-8. PubMed ID: 4048241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphetamine psychosis: overview and a hypothesis.
    Siomopoulos V
    Dis Nerv Syst; 1975 Jun; 36(6):336-9. PubMed ID: 1149593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.